Skip to main content

Table 3 Characteristics of the included bone lesions

From: Whole-body low-dose CT can be of value in prostate cancer decision-making: a retrospective study on 601 patients

Characteristic of bone lesions

Metastatic (n = 305) number (%)

Benign (n = 204) number (%)

Odds ratio (95% CI)

p value

Site of detected lesion

 Pelvis

127 (41.6)

91 (44.6)

NA

NA

 Vertebrae

70 (23.0)

57 (27.9)

 Rib

42 (13.8)

32 (15.6)

 Humerus

11 (3.6)

4 (2.0)

 Femur

20 (6.5)

12 (5.9)

 Scapula

19 (6.2)

4 (2.0)

 Skull

7 (2.3)

0 (0)

 Sternum

7 (2.3)

2 (1.0)

 Clavicle

2 (0.7)

2 (1.0)

Nature

 Purely lytic

21 (6.9)

16 (7.8)

NA

0.696*

 Purely sclerotic

174 (57.1)

175 (85.8)

 Mixed

16 (5.2)

13 (6.4)

 No underlying CT finding

94 (30.8)

Soft tissue component

17 (5.6)

4 (2.0)

3.0 (1.0–8.9)

0.044

Ill-defined lesion

99 (32.5)

30 (14.7)

2.8 (1.8–4.4)

 < 0.001

Size > 1 cm

161 (85.6)

68 (33.3)

2.2 (1.5–3.2)

 < 0.001

Cortical destruction

24 (7.9)

7 (3.4)

2.4 (1.0–5.7)

0.040

Asymmetric growth

132 (43.3)

74 (36.3)

NA

0.114

Mean Hounsfield unit

537 ± 244.3

809.4 ± 376.5

NA

 < 0.001

  1. Bolded p-values are < 0.05
  2. *p value was calculated among the lesions that had underlying CT finding
  3. *NA not applicable